Moderna Faces MRNA Vax Patent Suits In Canada And Beyond

By Theresa Schliep · March 4, 2025, 8:04 PM EST

Pennsylvania drug developer Arbutus Biopharma and Genevant Sciences have taken their COVID-19 vaccine litigation against Moderna worldwide, suing the pharmaceutical company in courts in Canada, Japan and Switzerland, along with the...

To view the full article, register now.

Case Information

Case Title

Arbutus Biopharma Corporation et al v. Moderna, Inc. et al

Case Number

1:22-cv-00252

Court

Delaware

Nature of Suit

Patent

Date Filed

February 28, 2022